Goldman Sachs
QGEN icon

Goldman Sachs’s Qiagen QGEN Stock Holding History

Goldman Sachs’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
295,000
-210,900
-42% -$7.83M ﹤0.01% 3119
2026
Q1 		$20.3M Buy
505,900
+4,200
+0.8% +$199K ﹤0.01% 2420
2025
Q4 		$22.6M Buy
501,700
+278,616
+125% +$12.9M ﹤0.01% 2266
2025
Q3 		$9.97M Buy
223,084
+42,900
+24% +$2.05M ﹤0.01% 2970
2025
Q2 		$8.66M Buy
180,184
+85,200
+90% +$3.71M ﹤0.01% 2886
2025
Q1 		$3.81M Sell
94,984
-48,224
-34% -$2.03M ﹤0.01% 3612
2024
Q4 		$6.56M Buy
143,208
+134,847
+1,613% +$6.04M ﹤0.01% 3186
2024
Q3 		$392K Sell
8,361
-134,847
-94% -$6.15M ﹤0.01% 5182
2024
Q2 		$6.05M Buy
+143,208
New +$6.28M ﹤0.01% 2984
2024
Q1 		– Sell
-47,153
Closed -$2.17M – 5818
2023
Q4 		$2.17M Sell
47,153
-47,153
-50% -$2.01M ﹤0.01% 3858
2023
Q3 		$4.05M Hold
94,306
– – ﹤0.01% 3174
2023
Q2 		$4.5M Hold
94,306
– – ﹤0.01% 3190
2023
Q1 		$4.59M Buy
+94,306
New +$4.8M ﹤0.01% 3145
2022
Q4 		– Sell
-235,764
Closed -$10.3M – 6217
2022
Q3 		$10.3M Buy
235,764
+141,458
+150% +$6.99M ﹤0.01% 2468
2022
Q2 		$4.72M Sell
94,306
-590,635
-86% -$28.8M ﹤0.01% 3191
2022
Q1 		$35.6M Buy
+684,941
New +$35.4M 0.01% 1591
2020
Q4 		– Sell
-13,203
Closed -$732K – 5662
2020
Q3 		$732K Buy
+13,203
New +$685K ﹤0.01% 4278
2020
Q2 		– Sell
-141,458
Closed -$6.24M – 5429
2020
Q1 		$6.24M Sell
141,458
-122,786
-46% -$4.8M ﹤0.01% 2469
2019
Q4 		$9.47M Buy
+264,244
New +$9.82M ﹤0.01% 2465
2018
Q2 		– Sell
-57,526
Closed -$1.97M – 5940
2018
Q1 		$1.97M Hold
57,526
– – ﹤0.01% 3612
2017
Q4 		$1.89M Sell
57,526
-37,723
-40% -$1.3M ﹤0.01% 3844
2017
Q3 		$3.18M Sell
95,249
-99,498
-51% -$3.43M ﹤0.01% 3567
2017
Q2 		$6.92M Sell
194,747
-21,137
-10% -$714K ﹤0.01% 2797
2017
Q1 		$6.63M Buy
+215,884
New +$6.65M ﹤0.01% 2703

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Goldman Sachs's QGEN Position: Q2 2026 in Review

Goldman Sachs increased its Qiagen (QGEN) stake by 219% in Q2 2026, buying an estimated $113M and bringing the position to 4,443,674 shares worth $174M. The position accounts for 0.02% of the portfolio, ranked #848.

Goldman Sachs first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $181M in Q4 2022. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Goldman Sachs held 4,443,674 shares of Qiagen worth $174M as of Q2 2026.
  • Goldman Sachs bought 3,052,347 Qiagen shares in Q2 2026, an estimated $113M.
  • Qiagen made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #848 holding.
  • Goldman Sachs first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
  • Goldman Sachs's Qiagen position peaked at $181M in Q4 2022.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.